Skip to content

Clinical trials

Phase 2 Insulin Resistance trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 2 Country / region: United States Clear all

125 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20036
20044
20057
20069
200712
200813
20095
20104
20117
20124
20131
20144
20159
20175
20184
20194
20205
20213
20223
20234
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed86
Terminated10
Recruiting8
Withdrawn8
Unknown status7
Not yet recruiting3
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)12
Massachusetts General Hospital5
Albert Einstein College of Medicine4
The University of Texas Health Science Center at San Antonio4
University of Alabama at Birmingham4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
Halozyme Therapeutics3
Mayo Clinic3
University of California, San Francisco3
Beth Israel Deaconess Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance125
Diabetes Mellitus27
Obesity24
Diabetes Mellitus, Type 219
Metabolic Syndrome16
Diabetes Mellitus, Type 113
Overweight11
Fatty Liver7
Glucose Intolerance7
Inflammation7

Trials

Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.

25 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.